Ledger.Open graph →
SEC Form D · filed December 21, 2017

BELLUS Health Inc

Offering
$9.6M
Sold
$9.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LAVAL, Quebec, Canada
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Roberto Bellini · Laval, Quebec, CanadaExec · DirectorDenis Garceau · Laval, Quebec, CanadaExecJoseph L. Rus · Laval, Quebec, CanadaDirectorFranklin L. Berger · Laval, Quebec, CanadaDirectorClarissa L. Desjardins · Laval, Quebec, CanadaDirectorYoussef L. Bennani · Laval, Quebec, CanadaDirectorFrancesco Bellini · Laval, Quebec, CanadaDirectorPierre L. Larochelle · Laval, Quebec, CanadaDirectorFrancois Desjardins · Laval, Quebec, CanadaExecTony Matzouranis · Laval, Quebec, CanadaExecGregory T. Robinson · Madison, WIExecDavid T. Lemont · Madison, WIDirectorHass Hassan · Denver, CODirectorMatt Boyce · Denver, CODirectorMike Murray · Denver, CODirectorChuck Marcy · Denver, COExec · DirectorAlexander Kubicek · Madison, WIDirectorCaroline Macgill · Denver, CODirectorJasper Van Brakel · Denver, COExecStephen Hughes · Denver, COExecPuneet T. Agarwal · Madison, WIExecJeremy S. Starkweather · Castle Rock, COExecJohn A. Wynne · Kenwood, OHDirectorJason F. Ylizaroe · Conroe, TXExec · DirectorStefan L. Wenger · Littleton, CODirectorScott Elaine Wright-Case · Brunswick, MEDirectorAlden Blease · Brunswick, MEDirectorTrevor Fencott · Edmonton, Alberta, CanadaExecHarvey A. Shapiro · Edmonton, Alberta, CanadaDirectorMike A. Vioncek · Edmonton, Alberta, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗